CEO Pascal Soriot said Europe was "falling behind" in attracting investment and needed to "invest more in what really matters ...

AstraZeneca PLC ADR closed 22.59% below its 52-week high of $87.68, which the company achieved on August 30th.

(Reuters) -AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical ...